Esperion has made another deal with a financial backer for an immediate cash haul in return for future revenue.
Esperion received $304.7 million from the …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
“Regulation is stifling innovation” seems to be a prevailing opinion among medtech leaders who believe the Food and Drug Administration’s rules are slowing medical device
Persistent Hallucinogenic Perception Disorder (HPPD) stands as a perplexing aftermath of psychedelic drug consumption, characterized by enduring visual anomalies and profound psychological impacts. With symptoms
You’re reading this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight